A lottery fund in the U.K. has enabled the purchase of about $72 million worth of MR equipment for hospitals throughout the country. Unfortunately, many scanners are stting idle, as the charitable contribution did not include operating expenses.
A lottery fund in the U.K. has enabled the purchase of about $72 million worth of MR equipment for hospitals throughout the country. Unfortunately, many scanners are stting idle, as the charitable contribution did not include operating expenses.
A survey conducted by the Royal College of Radiologists found that many scanners given to hospitals through the lottery came with insufficient funds to run them at maximum capacity, said Dr. Paul Dubbins, dean of the faculty of clinical radiology at the Royal College. Although the lottery fund has added more than 50 MR scanners in the U.K., waiting times for exams have increased to 18 months in some hospitals.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.
2 Commerce Drive
Cranbury, NJ 08512